AI-Powered test aims to predict best cancer treatment for each patient
Diagnosis
Not yet recruiting
This study tests a new platform called xDRIVE that combines drug sensitivity testing and AI to predict which treatments will work best for people with advanced colorectal cancer. The platform will not provide treatment itself but will give doctors a recommendation. The goal is to…
Sponsor: First Ascent Biomedical Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 17:44 UTC